INHIBINOL Trademark

Trademark Overview


On Thursday, September 9, 2021, a trademark application was filed for INHIBINOL with the United States Patent and Trademark Office. The USPTO has given the INHIBINOL trademark a serial number of 97020058. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2024. This trademark is owned by Skymount Technologies LLC. The INHIBINOL trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of COVID-19, colds and flu, coronavirus disease, cardiovascular diseases and disorders, respiratory infections, eye infections, and respiratory diseases and disorders; anti-inflammatory preparations; anti-inflammatories; nutraceuticals for the treatment of respiratory and dietary diseases; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; botanicals extracts for the treatment of colds and flu; cardiovascular nutraceutical preparations; herbal supplements for the treatment of the respiratory system; nutraceuticals for regulating the immune system; nutraceuticals for the treatment of infectious diseases, namely, respiratory infections, eye infections; nutraceuticals for the treatment of respiratory diseases, disorders and infections; nutraceuticals for the treatment of the respiratory system; nutraceuticals for treatment or preventi...

Vitamins for use in the manufacture of nutraceuticals

Development of pharmaceutical preparations, nutraceuticals, and medicines; pharmaceutical and nutraceutical product development services; research and development of new products for others; drug and nutraceutical product discovery services in the nature of product research; AI-driven development of pharmaceutical preparations, nutraceuticals, and medicines; research and development of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical and nutraceutical product evaluation
inhibinol

General Information


Serial Number97020058
Word MarkINHIBINOL
Filing DateThursday, September 9, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Goods and ServicesNutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of COVID-19, colds and flu, coronavirus disease, cardiovascular diseases and disorders, respiratory infections, eye infections, and respiratory diseases and disorders; anti-inflammatory preparations; anti-inflammatories; nutraceuticals for the treatment of respiratory and dietary diseases; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; botanicals extracts for the treatment of colds and flu; cardiovascular nutraceutical preparations; herbal supplements for the treatment of the respiratory system; nutraceuticals for regulating the immune system; nutraceuticals for the treatment of infectious diseases, namely, respiratory infections, eye infections; nutraceuticals for the treatment of respiratory diseases, disorders and infections; nutraceuticals for the treatment of the respiratory system; nutraceuticals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; nutraceuticals for treating respiratory diseases; nutraceuticals for the treatment of coronavirus diseases and COVID-19; vitamin and mineral preparations for medical use
Goods and ServicesVitamins for use in the manufacture of nutraceuticals
Goods and ServicesDevelopment of pharmaceutical preparations, nutraceuticals, and medicines; pharmaceutical and nutraceutical product development services; research and development of new products for others; drug and nutraceutical product discovery services in the nature of product research; AI-driven development of pharmaceutical preparations, nutraceuticals, and medicines; research and development of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical and nutraceutical product evaluation

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, October 19, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 15, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINHIBINOL AI C- CORP
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMETAIRIE, LA 70002

Party NameSkymount Technologies LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew Orleans, LA 70130

Party NameSkymount Technologies LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Orleans, LA 70130

Trademark Events


Event DateEvent Description
Monday, September 13, 2021NEW APPLICATION ENTERED
Tuesday, October 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 9, 2022ASSIGNED TO EXAMINER
Tuesday, March 15, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 15, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, March 15, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 15, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, March 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 21, 2022ASSIGNED TO LIE
Thursday, March 24, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2022SOU EXTENSION 1 FILED
Thursday, December 15, 2022SOU EXTENSION 1 GRANTED
Saturday, December 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 19, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 19, 2023SOU EXTENSION 2 FILED
Monday, June 19, 2023SOU EXTENSION 2 GRANTED
Wednesday, June 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023SOU EXTENSION 3 GRANTED
Thursday, December 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 14, 2023SOU EXTENSION 3 FILED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Saturday, December 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED